At The Psychedelic Healthcare Forum, co-hosted by Psychedelic Alpha and Horizons in New York on October 15th, we dedicated a significant portion of our afternoon programming to a question that has loomed large in the field of late: Once a psychedelic is approved, how does it actually reach patients, and who pays? The block was moderated by Jazz Glastra, Senior Director at BrainFutures…


